Autoimmune Disease Diagnostics Market Report 2024 - Key Company Profiles, Strategy, Financial Insights, Recent Developments and Forecast to 2032 - ResearchAndMarkets.com

The "Autoimmune Disease Diagnostics Market (By Disease, Test Types, Country Analysis), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.

The global autoimmune disease diagnostics market was valued at US$ 5.90 Billion in 2023, and the market is predicted to reach US$ 11.63 Billion by 2032.

The autoimmune disease diagnostics market plays a crucial role in the early detection, accurate diagnosis, and monitoring of autoimmune diseases. The tests used to diagnose the autoimmune disease include auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate. The rising prevalence of diseases such as rheumatoid arthritis, lupus, Hashimoto's thyroiditis, and presence of favorable government regulations will render significant impact on the autoimmune disease diagnostics market growth.

Furthermore, the awareness of autoimmune diseases is increasing globally, both among the public and healthcare professionals. As patients become more informed about the symptoms of autoimmune disorders, they are more likely to seek diagnostic tests, leading to higher demand for specialized diagnostic services, thereby fueling the market growth.

By Disease: Global Autoimmune Disease Diagnostics Market Key Takeaways

• Based on disease, localized autoimmune disease segment dominated the global market in 2023, and should show a similar trend over the forecast period owing to the increasing prevalence of gastrointestinal autoimmune diseases such as Crohn's disease, Grave's disease and multiple sclerosis affecting the specific organ.
• Multiple sclerosis held highest share of the global localized autoimmune disease diagnostics market, followed by Inflammatory bowel disease segment. Multiple sclerosis affects approximately 1 million individuals in the US and 2.8 million worldwide.
• Systemic autoimmune disease diagnostics segment will witness robust growth over the forecast timeframe. Systemic autoimmune diseases are a broad range of related diseases characterized by dysregulation of immune system which give rise to activation of immune cells to attack autoantigens and results in inappropriate inflammation and multi-tissue damages.
• Rheumatoid Arthritis accounted for lion's share of the global systemic autoimmune disease diagnostics market in 2023, followed by Systemic lupus erythematosus (SLE). The reported prevalence of systemic lupus erythematosus (SLE) in the United States is 20 to 150 cases per 100,000.

By Tests Type: Global Autoimmune Disease Diagnostics Market Key Takeaways

• Based on test types, Autoantibody test captured highest share of the overall autoimmune disease diagnostics market in 2023, followed by the antinuclear antibodies (ANA) test. Antinuclear antibody (ANA) testing is an important tool to diagnose and manage autoimmune diseases such as Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis, at both the subspecialty settings and primary care.
• The complete blood count (CBC) is one of the most commonly ordered blood tests to diagnose and manage autoimmune diseases such as Systemic Lupus Erythematosus (SLE), Idiopathic Thrombocytopenic Purpura and Multiple Sclerosis.
• The increasing number of infections leading to various health hazards would contribute to the rising number of Erythrocyte Sedimentation Rate (ESR) tests, which in turn would drive the ESR tests market in the near future.
• Urinalysis Tests and Comprehensive Metabolic Panel Tests are competing closely with each other to grab maximum share of the pie.

By Region: Autoimmune Disease Diagnostics Market Key Takeaways

• North America dominates the global autoimmune disease diagnostics market and is likely to maintain its dominance over the forecast period.
• The United States autoimmune disease diagnostics market was valued at nearly US$ 2 Billion in 2023.
• Europe is the second largest region for autoimmune disease diagnostics market. It is estimated that the prevalence rate of multiple sclerosis in Europe is 83 out of 100,000.
• Germany has one of the most developed healthcare systems in Europe, and the growing prevalence of autoimmune diseases, coupled with advancements in diagnostic technology, is driving the market growth.
• In the United Kingdom, autoimmune disorders affect about 10% of the population, with 13% of women and 7% of men affected.
• Asia-Pacific is expected to be the fastest-growing autoimmune disease diagnostics market over the forecast period owing to the rising population, increasing prevalence of autoimmune disorders, and increasing private-public partnerships for improvement of healthcare sector.
• The China autoimmune disease diagnostics market is predicted to more than double by 2032 from its market value in 2023.

Recent Developments

• In June 2023, EUROIMMUN Medizinische Labordiagnostika AG (Germany) launched a new automated indirect immunofluorescence test (IIFT) system, 'UNIQO 160'. This system is used for the diagnosis of autoimmune diseases.
• In May 2023, Thermo Fisher Scientific introduced the Autoimmune Assay Kit, designed to provide rapid and accurate results for autoimmune disease detection. This new product is expected to improve diagnostic capabilities and patient management.
• In March 2023, Trinity Biotech launched a new diagnostic assay, the Autoimmune Panel Plus. This product offers enhanced accuracy and speed in detecting various autoimmune diseases, significantly improving diagnostic workflows in clinical laboratories.

This report has been analyzed from 8 View Points:

• Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)
• Global Autoimmune Disease Diagnostics Market Share and Forecast (2015 - 2032)
• By Disease - Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)
• By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)
• By Region - Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)
• Autoimmune Disease Diagnostics Market - Company Profiles
• Global Autoimmune Disease Diagnostics Market - Recent Developments
• Global Autoimmune Disease Diagnostics Market - Growth Drivers & Challenges

By Disease - Global Autoimmune Disease Diagnostics Market and Forecast

• Systemic Autoimmune Disease Diagnostics Market
• Rheumatoid Arthritis
• Ankylosing Spondylitis
• Systemic Lupus Erythematosus
• Others Systemic Autoimmune Disease
• Localized Autoimmune Disease Diagnostics Market
• Inflammatory Bowel Disease
• Multiple Sclerosis
• Type 1 Diabetes
• Hashimoto's Thyroiditis
• Others Localized Autoimmune Disease

By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast

• Autoantibody Tests
• Antinuclear Antibody (ANA) Tests
• Complete Blood Count Tests
• Erythrocyte Sedimentation Rate Tests
• C- Reactive Protein (CRP) Tests
• Urinalysis Tests
• Comprehensive Metabolic Panel Tests
• Others Tests

Autoimmune Disease Diagnostics Market - Key Company Profiles

• Abbott Laboratories
• Siemens Healthineers
• Roche Diagnostics
• bioMerieux
• EUROIMMUN
• Bio-Rad Laboratories
• Quest Diagnostics
• Thermo Fischer Scientific
• Danaher

Key Topics Covered:

1. Executive Summary

2. Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)

3. Global Autoimmune Disease Diagnostics Market Share and Forecast (2015 - 2032)

3.1 By Disease - Global Autoimmune Disease Diagnostics Market Share and Forecast

3.2 By Disease - Global Systemic Autoimmune Disease Diagnostics Market Share and Forecast

3.3 By Disease - Global Localized Autoimmune Disease Diagnostics Market Share and Forecast

3.4 By Test Type - Global Autoimmune Disease Diagnostics Market Share and Forecast

3.5 By Region - Global Autoimmune Disease Diagnostics Market Share and Forecast

4. By Disease - Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)

4.1 Global Systemic Autoimmune Disease Diagnostics Market and Forecast

4.2 Global Localized Autoimmune Disease Diagnostics Market and Forecast

5. By Test Type - Global Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)

5.1 Autoantibody Tests Market and Forecast

5.2 Antinuclear Antibody (ANA) Tests Market and Forecast

5.3 Complete Blood Count Tests Market and Forecast

5.4 Erythrocyte Sedimentation Rate Tests Market and Forecast

5.5 C- Reactive Protein (CRP) Tests Market and Forecast

5.6 Urinalysis Tests Market and Forecast

5.7 Comprehensive Metabolic Panel Tests Market and Forecast

5.8 Other Test Market and Forecast

6. By Region - Autoimmune Disease Diagnostics Market and Forecast (2015 - 2032)

6.1 North America - Autoimmune Disease Diagnostics Market and Forecast

6.2 Europe - Autoimmune Disease Diagnostics Market and Forecast

6.3 Asia Pacific - Autoimmune Disease Diagnostics Market and Forecast

6.4 South America - Autoimmune Disease Diagnostics Market and Forecast

6.5 Middle East & Africa - Autoimmune Disease Diagnostics Market and Forecast

7. Autoimmune Disease Diagnostics Market - Company Profiles

7.1 Abbott Laboratories

7.2 Siemens Healthineers

7.3 Roche Diagnostics

7.4 bioMerieux

7.5 EUROIMMUN

7.6 Bio-Rad Laboratories

7.7 Quest Diagnostics

7.8 Thermo Fischer Scientific

7.9 Danaher Corporation

8. Global Autoimmune Disease Diagnostics Market - Recent Developments

9. Global Autoimmune Disease Diagnostics Market - Growth Drivers

10. Global Autoimmune Disease Diagnostics Market - Challenges

For more information about this report visit https://www.researchandmarkets.com/r/qyljzd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241217294821/en/